To see the other types of publications on this topic, follow the link: Vulvovaginal.

Books on the topic 'Vulvovaginal'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 28 books for your research on the topic 'Vulvovaginal.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse books on a wide variety of disciplines and organise your bibliography correctly.

1

Mendling, Werner. Vulvovaginal Candidosis. Berlin, Heidelberg: Springer Berlin Heidelberg, 1988. http://dx.doi.org/10.1007/978-3-642-83312-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

1932-, Ledger William J. Vulvovaginal infections. Washington: Amer Soc For Microbiology, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Vulvovaginal dermatology. Philadelphia, Pa., [etc.]: Saunders, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Vulvovaginal candidosis: Theory and practice. Berlin: Springer-Verlag, 1988.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

L, Michels Dia, ed. A woman's guide to yeast infections. New York: Pocket Books, 1992.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Paula, Spencer, ed. The V book: A doctor's guide to complete vulvovaginal health. New York: Bantam Books, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Association, British Medical, ed. Understanding thrush, cystitis and women's genital symptoms. Poole: Family Doctor, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Parker, Philip M., and James N. Parker. Vaginal yeast infection: A medical dictionary, bibliography, and annotated research guide to Internet references. San Diego, CA: ICON Health Publications, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Parker, Philip M., and James N. Parker. Yeast infections: A medical dictionary, bibliography, and annotated research guide to internet references. San Diego, CA: ICON Health Publications, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Witkin, Steven S., and William J. Ledger. Vulvovaginal Infections. Taylor & Francis Group, 2016.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
11

Vulvovaginal Infections. American Society for Microbiology, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
12

Ledger, William J., and Steven S. Witkin. Vulvovaginal Infections. American Society of Microbiology, 2007. http://dx.doi.org/10.1128/9781555814748.

Full text
APA, Harvard, Vancouver, ISO, and other styles
13

Vulvovaginal Infections, Second Edition. CRC Press, 2016. http://dx.doi.org/10.1201/9781315381534.

Full text
APA, Harvard, Vancouver, ISO, and other styles
14

Mendling, Werner, Dora Wirth Languages Ltd, and H. Rieth. Vulvovaginal Candidosis: Theory and Practice. Springer, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
15

1926-, Richardson Robert G., ed. Fluconazole and its role in vaginal candidiasis: Proceedings of a symposium sponsored by Pfizer Ltd. and held at the Royal Society of Medicine, 1 Wimpole Street, London W1, on 11 October 1988. London: Royal Society of Medicine Services, 1989.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
16

Kilmartin, Angela. Victims of Thrush and Cystitis. Arrow Books Ltd, 1986.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
17

D, Sobel Jack, ed. Vulvovaginal infections: Current concepts in diagnosis and therapy. New York: Academy Professional Information Services, Inc., 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
18

Sobel, Jack D. Clinical Perspectives: Terconazole, an Advance in Vulvovaginal Candidiasis Therapy. McGraw, 1988.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
19

Stewart, Elizabeth Gunther, and Paula Spencer. The V Book: A Doctor's Guide to Complete Vulvovaginal Health. Tandem Library, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
20

Stewart, Elizabeth G., and Paula Spencer. The V Book: A Doctor's Guide to Complete Vulvovaginal Health. Bantam, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
21

Török, M. Estée, Fiona J. Cooke, and Ed Moran. Sexually transmitted infections. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199671328.003.0018.

Full text
Abstract:
This chapter covers the diagnosis and management of sexually transmitted infections, including bacterial vaginosis, with causes including vaginal discharge, vulvovaginal candidiasis, and trichomoniasis. The chapter also covers vulvovaginal candidiasis, genital warts or anogenital warts caused by human papillomavirus, tropical genital ulceration (which is commoner in patients presenting with sexually transmitted infections in the developing world and is an important factor in the spread of HIV), genital herpes, pelvic inflammatory disease, toxic shock syndrome, gonorrhoea, chlamydia, trichomoniasis, and syphilis.
APA, Harvard, Vancouver, ISO, and other styles
22

D, Sobel Jack, and Wayne State University. School of Medicine., eds. Clinical perspectives: Terconazole, an advance in vulvovaginal candidiasis therapy : proceedings from a symposium, Laguna Niguel, California, October 15-16, 1987. New York, NY: BMI/McGraw-Hill, 1988.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
23

1929-, Ludwig Hans, and International Workshop on Mycoses of the Female Genital Tract (1987 : Luxembourg, Luxembourg), eds. Mycoses of the female genitals: Current diagnostics and therapy : International Workshop, Luxembourg, October 31, 1987. Stuttgart: Schattauer, 1988.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
24

Yeast Infections, Trichomoniasis, and Toxic Shock Syndrome (Girls' Health). Rosen Publishing Group, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
25

Sobel, Jack D. Genito-urinary fungal infections. Edited by Christopher C. Kibbler, Richard Barton, Neil A. R. Gow, Susan Howell, Donna M. MacCallum, and Rohini J. Manuel. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780198755388.003.0027.

Full text
Abstract:
The predominant fungal causes of genitourinary disease are Candida spp.; other fungal genera are uncommon pathogens in both sexes. Vulvovaginal candidiasis affects millions of women worldwide—and includes acute sporadic, recurrent, and chronic syndromes—and considerable progress has been made in understanding its pathophysiology and hence the best therapy. Therapeutic options are still limited, however, and misdiagnosis is common. In contrast, urinary tract candidiasis reflects an entirely different pathogenesis and clinical expression affecting a predominantly hospital-based older population. Candida organisms are extremely difficult to eradicate from often complicated urinary tract infections. Non-Candida fungal species reach the kidney and prostate by the bloodstream rather than the ascending route taken by Candida spp. In women, not infrequently, there is simultaneous lower genital tract and urinary tract infection, requiring attention to both systems.
APA, Harvard, Vancouver, ISO, and other styles
26

Spadt, Susan Kellogg, and Jennifer Yonaitis Fariello. Complementary and Alternative Treatments for Female Sexual Pain (DRAFT). Edited by Madeleine M. Castellanos. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190225889.003.0016.

Full text
Abstract:
An estimated 17–19% of women in the United States suffer from chronic sexual pain and dyspareunia of vulvovaginal origin. The majority will see several health care providers in an effort to comprehensively diagnose, evaluate, and decide on a management strategy for the condition. As a result of countless encounters with health care providers, and after trying numerous unsuccessful traditional medical interventions woman can feel frustrated and look to the use of complementary and alternative solutions to “solve their sexual health mystery.” According to the 2007 National Health Interview Survey, an estimated 83 million adults in the United States spent $33.9 billion dollars on complementary and alternative medicine. Complementary therapies, including psychotherapy, physical therapy, and behavioral modification strategies, are becoming increasingly popular for women who are seeking treatment of chronic sexual pain either as a first-line therapy monotherapy or as cotherapies added to traditional medical pharmacotherapy.
APA, Harvard, Vancouver, ISO, and other styles
27

Wong, Germaine, and Angela C. Webster. Cancer after kidney transplantation. Edited by Jeremy R. Chapman. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199592548.003.0287.

Full text
Abstract:
Cancer is a major cause of mortality and morbidity after transplantation. The overall risk of cancer among transplant recipients is at least 2.5–3-fold greater than that of the age- and gender-matched general population. The increased risk is also type specific, and is greatest among virus-related neoplasms such as Kaposi sarcoma, post-transplant lymphoproliferative disease, and vulvovaginal cancers, with an excess risk of at least 9–20 times greater than that of the general population. Cancer prognoses are also poor in transplant recipients, with less than 10% surviving 5 years after initial diagnoses. Despite the increased cancer risk, little is known about the efficacy of treatment, the screening strategies, and the outcomes of patients with cancer and kidney transplants. Uncertainties also exist as to how the various types of modern immunosuppression impact on recipients’ overall long-term survival and quality of life. This chapter discusses the incidence and prognoses of patients with de novo cancer after transplantation, the epidemiology of donor cancer transmission, the outcomes of transplanting patients with a prior history of cancer, as well as the different approaches to cancer screening and management after kidney transplantation.
APA, Harvard, Vancouver, ISO, and other styles
28

MacLean, Allan B. Vulval pain. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780198749547.003.0009.

Full text
Abstract:
Vulval pain or pain involving the vulval tissue is discussed in Chapter 9. It becomes chronic when lasting for at least three months. Vulvodynia is a subset of chronic vulval pain, once known causes (infective, inflammatory, neoplastic, neurological, traumatic, iatrogenic and hormone deficiencies) are excluded. It reportedly affects one in six women at some stage of their lives. Uncertain terminology has hampered understanding. Even the latest classification from the International Society for the Study of Vulvovaginal Disease has deficiencies but it allows the discarding of previously used unhelpful terms. Differentiating features between provoked (entry dyspareunia), and unprovoked, localised and generalised, overlap, both in diagnosis and management. Older theories on causation included infection, irritation and inflammation but laboratory-based research has not supported these. Hormonal and neural mechanisms seem more likely to cause the pain, while the interplay of biological, psychological, and social factors has recently gained credence. Publications on successful management demonstrate a powerful placebo effect. The role of specially designated vulval pain clinics, multidisciplinary approaches, and team working is emphasised. General measures in vulval care, such as wearing clothes made of natural fibre, using emollients or carrying out pelvic floor exercises besides reducing stress, can minimise the pain. Topical anaesthetic creams or systemic treatments with antidepressants or anti-epileptics have advocates. Treatment is most effective when careful selection, adequate counselling, and ongoing psychosomatic evaluation address all the interactive factors that initiate, and maintain vulval pain besides modulating patient response. Case scenarios illustrate the complexities of diagnosis and management.
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography